Cher sues Dr. Patrick Soon-Shiong over healthcare stock fraud

Julie Spitzer - Print  | 

Cher is suing billionaire physician and entrepreneur Patrick Soon-Shiong, MD, over fraud related to investments in a Miramar, Fla.-based biopharmaceutical company Altor BioScience, reports the Los Angeles Times.

The entertainer purchased her stake in the company in 2013 for an undisclosed price. In January 2016, she sold her shares back to the company for $1.50 each. Now, she contends the sale to have occurred at "an unreasonably below-market price," according to the lawsuit filed Friday.

The lawsuit alleges fraudulent concealment and breach of fiduciary duty since the company never alerted Cher that some compounds of an Altor drug were advancing in clinical trials for cancer and HIV/AIDS.

In early 2016, Dr. Soon-Shiong acquired the outstanding shares of Altor for about $15 million, but the lawsuit claims the company is now worth "over $1 billion."

A spokesman for Dr. Soon-Shiong said the lawsuit has no merit and they plan to fight it vigorously, according to the LA Times.

Other stakeholders have filed similar, separate lawsuits.

More articles on legal & regulatory issues:  

Former Las Vegas hospital CEO's second theft trial barred by double jeopardy
Ex-CFO of Florida medical group settles false billing allegations for $100k
Former Cleveland Clinic executive charged in $2.7M fraud scheme

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.